Copertina

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Luis Fernando Valladales‐Restrepo, Ana Camila Delgado‐Araujo, María Camila Oyuela‐Gutiérrez, John Alexander López‐Rincón, Andrés Gaviria‐Mendoza, Manuel Enrique Machado‐Duque, María Fernanda Hernández‐Giraldo, Juan Pablo Albanes‐Beltran, Jorge Enrique Machado‐Alba
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Pharmacoepidemiology and Drug Safety
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Use of Valproic Acid Among Women of Childbearing Age and Its Concomitant Use With Contraceptives in Colombia
di: Jorge E. Machado‐Alba, et al.
Pubblicazione: (2025)

Assessment of Off‐Label Psychotropic Drug Use in Children and Adolescents: A Multi‐Center Cross‐Sectional Study in China
di: Yue‐Peng Teng, et al.
Pubblicazione: (2026)

The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population
di: John E. Hughes, et al.
Pubblicazione: (2025)

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
di: W. N. Kelly, et al.
Pubblicazione: (2024)

Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002–2025
di: Julio C. Nunes, et al.
Pubblicazione: (2026)

Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review
di: Xabier Aizpurua‐Arruti, et al.
Pubblicazione: (2025)

Drug Safety: Being Vigilant… or Proactive?
di: Alain Braillon
Pubblicazione: (2026)

A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
di: Matthew R. Muschett, et al.
Pubblicazione: (2024)

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
di: Wanqi Wang, et al.
Pubblicazione: (2024)

Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study
di: Y. Shi, et al.
Pubblicazione: (2025)

Time Windows Used When Identifying Current Drug Use and Polypharmacy
di: Sabrina Giometto, et al.
Pubblicazione: (2026)

A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety
di: Ryan Muddiman, et al.
Pubblicazione: (2026)

Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies
di: Araniy Santhireswaran, et al.
Pubblicazione: (2024)

A Cross‐Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real‐World Evidence
di: Maria Melinder, et al.
Pubblicazione: (2026)

Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe
di: Makoto Onohara, et al.
Pubblicazione: (2025)

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications
di: Anjali D. Deshmukh, et al.
Pubblicazione: (2024)

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
di: Katie J. Suda, et al.
Pubblicazione: (2026)

Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries
di: Marcelo Bueno de Camargo, et al.
Pubblicazione: (2025)

Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies ( CNODES )
di: Alexandra M. Yip, et al.
Pubblicazione: (2026)

Biologics Used for Psoriasis: A Drug Utilization Study Based on Two Nationwide Danish Data Sources
di: Nanna Philbert Engel‐Andreasen, et al.
Pubblicazione: (2024)

Performance of the Self‐Controlled Case Series for Drug Safety Signal Detection: A Multi‐Database Study
di: Astrid Coste, et al.
Pubblicazione: (2026)

Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database
di: Sarah R. Hoffman, et al.
Pubblicazione: (2024)

Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis
di: Lanting Yang, et al.
Pubblicazione: (2025)

Methodological Characteristics in Economic Evaluations of Health Technology Assessment Reports Submitted for Drug Reimbursement in Brazilian Public Health
di: Gilson Pires Dorneles, et al.
Pubblicazione: (2026)

Treatment Persistence and Variations in Prescribing Oral, Injectable, and Inhaled Corticosteroids: A Population‐Based Drug Utilisation Study
di: Eleni Domzaridou, et al.
Pubblicazione: (2025)

Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach
di: Kirsten M. Woolpert, et al.
Pubblicazione: (2025)

Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
di: Rowan E. Parry, et al.
Pubblicazione: (2025)

Incidence and Clinical Significance of Drug‐Induced Antibodies and Hemolytic Anemia Associated With Beta‐Lactam Antibiotics: A Prospective Cohort Study
di: Li Wang, et al.
Pubblicazione: (2026)

Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study
di: Maeve E. Wickham, et al.
Pubblicazione: (2024)

Knowledge, Attitudes and Sources of Information About Adverse Drug Reactions—A Survey Study Among Patients and Healthcare Professionals in Poland
di: Magdalena Niedzielko, et al.
Pubblicazione: (2026)

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)
di: Isatu Jalloh, et al.
Pubblicazione: (2026)

Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study
di: Min Fan, et al.
Pubblicazione: (2025)

Effect of Deregulation of the Brazilian National Controlled Products Management System on Antidepressants' Sales Data Deregulation of a Brazilian Drug Electronic System
di: Vanessa Gomes Lima, et al.
Pubblicazione: (2025)

Agreement of Medication Information Derived From EHR Data Compared to Medicare Insurance Claims: An Analysis of Biologic Disease‐Modifying Antirheumatic Drugs
di: Jing Li, et al.
Pubblicazione: (2024)

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink ( CPRD )
di: Astrid Coste, et al.
Pubblicazione: (2025)

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using Merative MarketScan Research Databases
di: Astrid Coste, et al.
Pubblicazione: (2025)

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS )
di: Astrid Coste, et al.
Pubblicazione: (2025)

Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019
di: Mengyuan Fu, et al.
Pubblicazione: (2024)

PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
di: Kazuhiro Kajiyama, et al.
Pubblicazione: (2024)

Correction to “Effect of Deregulation of the Brazilian National Controlled Products Management System on Antidepressants’ Sales Data Deregulation of a Brazilian Drug Electronic System”
Pubblicazione: (2025)